GT Biopharma(DE:OXI)
€119.250.00 (0.00%)
DE:OXI
GT Biopharma earnings date
€119.25
At close:0.00 (0.00%)
GT Biopharma (OXI) Q2 2023 Earnings Report
0 Followers
DE:OXI Q2 2023 EPS Results
- Actual EPS
- -EUR 37.63
- Consensus EPS
- -EUR 68.40
- Beat/Miss
- Beat by +EUR 30.77
- One Year Ago EPS
- -EUR 68.40
DE:OXI Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/07/2023
- Time
- Before Open
- Conference Call
- Monday, August 7, 2023
DE:OXI Upcoming Earnings
GT Biopharma's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OXI Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | -50.61 | ― | ― |
| Nov 16, 2026 | 2026 (Q3) | -2.28-1.80 | -18.92 | 90.48% (+17.12) | |
| Aug 14, 2026 | 2026 (Q2) | -1.82-2.74 | -12.54 | 78.18% (+9.80) | |
| May 18, 2026 | 2026 (Q1) | -0.10-0.10 | -0.3 | 66.67% (+0.20) | |
| Apr 01, 2026 | 2025 (Q4) | -5.02-50.61 | -38.08 | -32.93% (-12.54) | |
| Nov 04, 2025 | 2025 (Q3) | -0.35-0.76 | -1.4 | 45.75% (+0.64) | |
| Aug 14, 2025 | 2025 (Q2) | -15.50-12.54 | -49.47 | 74.65% (+36.94) | |
| May 19, 2025 | 2025 (Q1) | -0.30-0.30 | -1.5 | 79.88% (+1.19) | |
| Feb 21, 2025 | 2024 (Q4) | -35.34-38.08 | -1.96 | -1846.39% (-36.12) | |
| Nov 14, 2024 | 2024 (Q3) | ―-34.88 | -41.04 | 15.00% (+6.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

